HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.

Abstract
Arsenic trioxide (As(2)O(3)) is an effective treatment for relapsed or refractory acute promyelocytic leukemia (APL). After the discovery of As(2)O(3) as a promising treatment for APL, several studies investigated the use of As(2)O(3) as a single agent in the treatment of solid tumors; however, its therapeutic efficacy is limited. Thus, the systematic study of the combination of As(2)O(3) with other clinically used chemotherapeutic drugs to improve its therapeutic efficacy in treating human solid tumors is merited. In this study, we demonstrate for the first time, using isobologram analysis, that As(2)O(3) exhibits a synergistic interaction with N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU). The synergistic augmentation of the cytotoxicity of As(2)O(3) with BCNU is in part through the autophagic cell death machinery in human solid tumor cells. As(2)O(3) and BCNU in combination produce enhanced cytotoxicity via the depletion of reduced glutathione (GSH) and augmentation of reaction oxygen species (ROS) production. Further analysis indicated that the extension of GSH depletion by this combined regimen occurs through the inhibition of the catalytic activity of glutathione reductase. Blocking ROS production with antioxidants or ROS scavengers effectively inhibits cell death and autophagy formation, indicating that redox-mediated autophagic cell death involves the synergism of As(2)O(3) with BCNU. Taken together, this is the first evidence that BCNU could help to extend the therapeutic spectrum of As(2)O(3). These findings will be useful in designing future clinical trials of combination chemotherapy with As(2)O(3) and BCNU, with the potential for broad use against a variety of solid tumors.
AuthorsChing-Chuan Kuo, Tsang-Wu Liu, Li-Tzong Chen, Her-Shyong Shiah, Ching-Ming Wu, Yen-Ting Cheng, Wen-Yu Pan, Jin-Fen Liu, Kuo-Li Chen, Yun-Ning Yang, Shan-Na Chen, Jang-Yang Chang
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 51 Issue 12 Pg. 2195-209 (Dec 15 2011) ISSN: 1873-4596 [Electronic] United States
PMID22001324 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Reactive Oxygen Species
  • Glutathione Reductase
  • Glutathione
  • arsenic trioxide
  • Carmustine
Topics
  • Antineoplastic Agents (pharmacology)
  • Arsenicals (pharmacology)
  • Autophagy (drug effects)
  • Carmustine (pharmacology)
  • Cell Death (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Drug Screening Assays, Antitumor
  • Glutathione (metabolism)
  • Glutathione Reductase (antagonists & inhibitors, metabolism)
  • Humans
  • Oxidation-Reduction
  • Oxides (pharmacology)
  • Reactive Oxygen Species (metabolism)
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: